5 results
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
Antiplatelet Conversion ... Switching Between Intravenous ... Inhibitor #switching #conversion ... Clopidogrel #plavix #antiplatelet ... ticagrelor #prasugrel #pharmacology
Common IV to PO Drug Conversions
1) Metoprolol 1:2.5
2) Diltiazem Oral Dose(mg/day) = [ rate (mg/hr) x
IV to PO Drug Conversions ... 2) Diltiazem Oral ... #Pharmacology # ... Common #Intravenous ... #Oral
Antiplatelet Conversion - P2Y12 Inhibitor Switching
 • Clopidogrel (Plavix)
 • Prasugrel (Effient)
 • Ticagrelor (Brilinta)
Clopidogrel and
Antiplatelet Conversion ... - P2Y12 Inhibitor ... @accpcardprn #Antiplatelet ... #Conversion #P2Y12 ... Inhibitor #Switching #pharmacology
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... P2Y12 Inhibitors ... CIRCULATIONAHA.117.031164 #P2Y12 ... Inhibitor #switching #conversion ... ticagrelor #prasugrel #pharmacology
Cangrelor - Pharmacology
Cangrelor (Kengreal) is a parenteral analogue of adenosine triphosphate
Cangrelor binds reversibly to the platelet
Cangrelor - Pharmacology ... pre-treated with an oral ... No oral/enteral ... CABG) - As antiplatelet ... from IV to PO Antiplatelet